squamous-cell-carcinoma

Documents about squamous-cell-carcinoma

• Association Between VEGF-C and miRNA and Clinical Non-small Cell Lung Cancer and Esophagus Squamous Cell Carcinoma#868428ClinicalTrials.gov
• Establishment and Histopathological Characterization of a KYSE-30 Subcutaneous Xenograft Model of Esophageal Squamous Cell Carcinoma#351835ODU Digital Commons
• Trial of the Combination of GX-188E Vaccination, GX-I7 and Pembrolizumab in Patients With Advanced, Resectable HPV Type 16 and/or 18 Positive Head and Neck Cancer#405201ClinicalTrials.gov
• Comparison of experimental and radiobiological model-predicted survival of human laryngeal squamous cell carcinoma cells in a helium spread-out Bragg peak#482531HAL (France)
• A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202#633721ClinicalTrials.gov
• Surufatinib Combined with Envolizumab As Second-line Treatment for Recurrent/Metastatic HNSCC#828581ClinicalTrials.gov
• TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers#879702ClinicalTrials.gov
• Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer#893261ClinicalTrials.gov
• MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)#844803ClinicalTrials.gov
• Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease#843377ClinicalTrials.gov
• Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer#888910ClinicalTrials.gov
• Prospective, Open-label, Multi-cohort Study of Becotatug Vedotin With Tislelizumab and Chemotherapy in Esophageal Squamous Cell Carcinoma - Phase 2#148778ClinicalTrials.gov
• A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers#261495ClinicalTrials.gov
• Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy#387139ClinicalTrials.gov
• A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.#398308ClinicalTrials.gov
• Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Jction CA#435742ClinicalTrials.gov
• Prospective multicentre study evaluating ctDNA as a biomarker of residual disease after chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: NeckTAR-IN protocol#643355HAL (France)
• Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma#834794ClinicalTrials.gov
• A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN#837251ClinicalTrials.gov
• Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma#841955ClinicalTrials.gov
• Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation#860457ClinicalTrials.gov
• A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors#837331ClinicalTrials.gov
• Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell Carcinoma#435734ClinicalTrials.gov
• Stratified Treatment in Unresectable Locally Advanced ESCC Without Progression After Chemoimmunotherapy Induction Plus CCRT: Toripalimab Consolidation vs observation--a Prospective, Randomized, Controlled Phase III Multicenter Study#162479ClinicalTrials.gov
• Base of tongue volume and dose as predictors of late dysphagia after definitive or adjuvant radiotherapy for oral cavity squamous cell carcinoma#635357HAL (France)
• 2D and 3D convolutional neural networks for outcome modelling of locally advanced head and neck squamous cell carcinoma#647828RODARE
• A Study of the Use of Fat Flap Reconstruction to Reduce Neck Injury After Cancer Treatment#831721ClinicalTrials.gov
• Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer#847772ClinicalTrials.gov
• Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHN#852664ClinicalTrials.gov
• HYPORT: A Phase I/II Study of Hypofractionated Post-operative Radiation Therapy for Head and Neck Cancer#865602ClinicalTrials.gov
• Study of CHS-114 in Participants With Advanced Solid Tumors#874371ClinicalTrials.gov
• Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer#891501ClinicalTrials.gov
• A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)#807635ClinicalTrials.gov
• A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors#890578ClinicalTrials.gov
• Influência do diagnóstico prévio das desordens orais com potencial de malignização na sobrevida global de pacientes com câncer de boca#305646Repositório da UFES
• A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors#832695ClinicalTrials.gov
• Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy#831626ClinicalTrials.gov
• PPIO-004 Clinical Application of Efficacy Prediction Model Based on Epigenomics Sequencing Technology in Neoadjuvant Immunotherapy for Esophageal Cancer#834143ClinicalTrials.gov
• State of the Art Photon Therapy Versus Particle Therapy for Recurrent Head & Neck Tumors; a Planning Study#876243ClinicalTrials.gov
• Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care#850879ClinicalTrials.gov
• Oral kavitenin skuamöz hücreli karsinomlarında immünohistokimyasal p53 , p16 ve Ki-67 boyanma özelliklerinin lenf nodu metastazı ile ilişkisi#260228Necmettin Erbakan University Institutional Repository
• The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer Study#831662ClinicalTrials.gov
• The Diagnostic Value of PET/MRI in Head and Neck Cancer#832740ClinicalTrials.gov
• A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)#880294ClinicalTrials.gov
• The Evolving Role of Taxanes in Combination With Cetuximab for the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Evidence, Advantages, and Future Directions#424395Dipòsit Digital de la Universitat de Barcelona
• Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote Areas#858833ClinicalTrials.gov
• PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY#865339ClinicalTrials.gov
• Phase III Trial of PET/CT vs. CTSurveilance for Head and Neck Cancer#892753ClinicalTrials.gov
• A Phase 1 Study of [225Ac]-FPI-1434 Injection#859603ClinicalTrials.gov
• Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors#829094ClinicalTrials.gov